GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocMorris AG (XSWX:DOCM) » Definitions » EV-to-EBIT

DocMorris AG (XSWX:DOCM) EV-to-EBIT : -11.92 (As of Apr. 29, 2024)


View and export this data going back to 2017. Start your Free Trial

What is DocMorris AG EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, DocMorris AG's Enterprise Value is CHF1,186.0 Mil. DocMorris AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-99.5 Mil. Therefore, DocMorris AG's EV-to-EBIT for today is -11.92.

The historical rank and industry rank for DocMorris AG's EV-to-EBIT or its related term are showing as below:

XSWX:DOCM' s EV-to-EBIT Range Over the Past 10 Years
Min: -66.24   Med: -13.7   Max: -2.33
Current: -11.92

During the past 13 years, the highest EV-to-EBIT of DocMorris AG was -2.33. The lowest was -66.24. And the median was -13.70.

XSWX:DOCM's EV-to-EBIT is ranked worse than
100% of 428 companies
in the Healthcare Providers & Services industry
Industry Median: 18.475 vs XSWX:DOCM: -11.92

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. DocMorris AG's Enterprise Value for the quarter that ended in Dec. 2023 was CHF1,047.2 Mil. DocMorris AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-99.5 Mil. DocMorris AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -9.50%.


DocMorris AG EV-to-EBIT Historical Data

The historical data trend for DocMorris AG's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DocMorris AG EV-to-EBIT Chart

DocMorris AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -24.09 -24.77 -12.64 -4.40 -10.52

DocMorris AG Semi-Annual Data
Dec12 Dec13 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.64 - -4.40 - -10.52

Competitive Comparison of DocMorris AG's EV-to-EBIT

For the Pharmaceutical Retailers subindustry, DocMorris AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DocMorris AG's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DocMorris AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where DocMorris AG's EV-to-EBIT falls into.



DocMorris AG EV-to-EBIT Calculation

DocMorris AG's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1186.043/-99.518
=-11.92

DocMorris AG's current Enterprise Value is CHF1,186.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. DocMorris AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-99.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DocMorris AG  (XSWX:DOCM) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

DocMorris AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-99.518/1047.249375
=-9.50 %

DocMorris AG's Enterprise Value for the quarter that ended in Dec. 2023 was CHF1,047.2 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. DocMorris AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-99.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DocMorris AG EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of DocMorris AG's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


DocMorris AG (XSWX:DOCM) Business Description

Traded in Other Exchanges
Address
Walzmuhlestrasse 60, Frauenfeld, CHE, 8500
DocMorris AG is an online pharmacy company and wholesale supplier to medical practitioners in Switzerland. The Group's reportable segments are Switzerland, Germany, and Europe. The operating segment in Switzerland comprises the wholesale business of supplying medical products to Swiss medical practitioners and the retail business that is focused on providing end consumers with drugs and health products from Zur Rose. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The operating segment Europe comprises the marketplace business of PromoFarma and Doctipharma. Majority of revenue is generated from Germany segment.

DocMorris AG (XSWX:DOCM) Headlines

No Headlines